comparemela.com

Lay Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Statera Biopharma, Lay Sciences announce intent to enter strategic partnership

Statera Biopharma has announced its intent to enter into a non-binding term sheet with regard to a strategic partnership with Lay Sciences.

Satish chandranStatera biopharmaMichaelk handleyLay sciences

Statera Biopharma and Lay Sciences Inc Announce Intent to Enter Strategic Partnership to License the Manufacturing Rights to Certain Lay Sciences IgY Products

FORT COLLINS, Colo., May 13, 2022 Statera Biopharma , a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today.

United statesRussian federationSatish chandranStatera biopharmaNichol ochsnerMichaelk handleyCleveland biolabsProdigy biotech incCompany annual report on formEuropean unionCorporate communicationsLay sciences incCytocom incLay sciencesGlobenewswire incLay science igy

Lay Sciences unveils COVID-19 neutralising antibody mouth wash

Global launch of ImmunIgY, the first pre-formed oral antibody that neutralizes SARS-CoV-2 and all its known variants

United kingdomProdigy biotech incEuropean unionLay sciencesReagene biosciencesProdigy biotechKyntox biotech india

vimarsana © 2020. All Rights Reserved.